特发性肺纤维化
细胞外基质
成纤维细胞
肺
肌成纤维细胞
肺纤维化
纤维化
人肺
癌症研究
医学
细胞外
细胞生长
细胞
效应器
生物
免疫学
内分泌学
转化生长因子
囊性纤维化
肺纤维化
内科学
电池类型
内生
呼吸道疾病
博莱霉素
下调和上调
病理
作者
Aaron K McDowell-Sanchez,Bieerkehazhi Shayahati,João Lucas Aleixes Sampaio Rocha,Alan R. Waich Cohen,Iván O. Rosas,Konstantin Tsoyi
标识
DOI:10.1016/j.bbrc.2026.154774
摘要
Idiopathic pulmonary fibrosis is a progressive lung disorder with limited therapeutic options. Fibroblasts and myofibroblasts are major effector cells in fibrosis through excessive extracellular matrix production and increased contractility. In this study, we investigated the effects of exportin-1 (XPO1) inhibitors on profibrotic responses in human lung fibroblasts. MRC-5 cells, primary control human lung fibroblasts, and idiopathic pulmonary fibrosis-derived human lung fibroblasts were stimulated with transforming growth factor-β1 (TGF-β1) in the presence of the XPO1 inhibitors KPT-185, eltanexor, or selinexor. XPO1 inhibition enhanced TGF-β1-induced profibrotic responses, as reflected by increased expression of fibrotic markers and greater fibroblast contractility. Similar effects were observed in both control and idiopathic pulmonary fibrosis-derived primary fibroblasts. The tested concentrations did not reduce cell viability. Although prior literature suggested that XPO1 inhibition might be antifibrotic, our results show that it worsens profibrotic activation rather than suppressing it.
科研通智能强力驱动
Strongly Powered by AbleSci AI